Tilray Brands (NASDAQ:TLRY) shares are trading lower on Thursday as the company is announcing a strategic partnership with several pharmaceutical entities in Germany.Tilray’s partnership involves collaboration with Tilray Medical, CC Pharma, and 14U Pharma, aimed at enhancing their market presence in Germany. Effective April 1, 2026, this alliance will allow the companies to offer a broader range of products and improve pharmacy access, leveraging CC Pharma’s established distribution network, which supports ...

DENSBORN, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), has announced a strategic partnership with Tilray Medical, CC Pharma, 14U Pharma, and “gesund leben” cooperation, which is operated by Alliance Healthcare Deutschland. As one of Germany’s largest pharmacy networks, Alliance Healthcare Deutschland runs 27 logistics centers across the country and supplies more than 10,000 pharmacies daily. This comprehensive distri ...

Pub Beer introduces a 99‑calorie American‑style light lager at 4% ABVBEND, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Pub Beer, the Cheap Fun beer brand by Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced the launch of Pub Light, a new American-style light lager built for easy drinking and long hangs. With 99 calories and 4% ABV, Pub Light delivers everything fans expect from Pub Beer — just lighter, cheaper, and funner. Pub Light skips additives, gimmicks, and over‑engineered tasting notes in ...

Industry Overview - The global cannabis industry is evolving with ongoing legalization across various regions, and Canadian cannabis producers play a significant role in this expansion [1][2] - Canada was the first major developed country to legalize recreational cannabis, leading to the establishment of early industry leaders with large cultivation facilities and recognizable brands [2] - Post-legalization, the Canadian cannabis market has faced challenges such as oversupply, price compression, and heavy regulations, prompting many companies to restructure operations [2] Market Dynamics - The industry is shifting towards efficiency and profitability, with companies focusing on cost reduction and margin improvement [3] - International medical cannabis markets, particularly in Europe, are becoming increasingly important, with countries like Germany expanding their medical cannabis programs [3] - The United States remains the largest potential cannabis market, and Canadian companies are preparing strategies for potential entry as federal reform discussions continue [4] Company Strategies - Diversification has become a key strategy for cannabis companies, with expansions into beverages, wellness products, and pharmaceutical research to generate additional revenue streams [5] - Canadian cannabis stocks are characterized by high volatility but still present significant upside potential for investors [5] Key Companies to Watch Tilray Brands Inc. - Tilray is one of the largest global cannabis companies, producing medical and recreational products and operating across cannabis, beverages, and wellness markets [6][10] - The company reported quarterly revenue exceeding $217 million in fiscal 2026, showing modest growth and improved operational efficiency [11] - Tilray's international sales, particularly in Europe, are growing, and the company is positioning itself for potential U.S. legalization through acquisitions and brand development [12][10] Canopy Growth Corporation - Canopy Growth is a major player in the cannabis industry, producing a wide range of products and maintaining strong brand recognition [13][14] - The company reported quarterly cannabis revenue of nearly $52 million, reflecting moderate year-over-year growth, while also focusing on restructuring to improve profitability [18] - Canopy has established a structure for potential U.S. market entry and holds interests in several American cannabis operators [16][17] Cronos Group Inc. - Cronos Group focuses on research and product innovation, emphasizing premium cannabis brands and cannabinoid development [20][24] - The company reported quarterly revenue of approximately $44.5 million, driven by higher sales of cannabis flower and international distribution [25] - Cronos benefits from significant financial backing from Altria, allowing for continued investment in research and development [24][26]

Editor's note: Seeking Alpha is proud to welcome Systems Capital as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.Systems Capital is a holdings company established to support the research and investment work of a dedicated analyst focused on identifying high-quality systems. Our investment philosophy centers on finding companies that have strong busine ...

Group 1 - Tilray Brands is focused on growth and has diversified its operations significantly over the years [1][2] - The company projects to achieve a record $1.2 billion in annualized revenue by fiscal 2027, marking a substantial milestone [2][7] - Tilray's beverage operations are crucial for its growth, with recent acquisitions of craft brewers, including BrewDog, enhancing its market presence [5][6] Group 2 - The beverage segment generated $106 million in revenue for the six-month period ending November 30, 2025, indicating strong growth potential [8] - Despite the growth, much of it has been driven by acquisitions rather than organic growth, raising questions about the sustainability of this growth model [9]

Tilray Brands has snapped up BrewDog's Australian assets for an undisclosed sum. The move follows the US-headquartered cannabis and beverage group confirming the acquisition of some of BrewDog's assets last week for £33m (then $44.1m). With the latest deal, Tilray acquires the BrewDog Brewing Australia business, which includes a brewing and production facility in Brisbane, Queensland, a statement from the cannabis and beverages group read today (9 March). The transaction will also see Tilray take owner ...

Core Viewpoint - The acquisition of BrewDog's Australian operations by Tilray Brands is a strategic move to enhance its global beverage and consumer products platform, leveraging BrewDog's established presence in the Australian craft beer market to expand into the Asia-Pacific region [1][2][3]. Group 1: Acquisition Details - The acquisition includes BrewDog's profitable brewery operations in Brisbane, Queensland, and two flagship bars, DogTap Brisbane and BrewDog Fortitude Valley, along with three franchised locations in Victoria, New South Wales, and Western Australia [1][2]. - This transaction is positioned to strengthen Tilray's international brewing footprint and enhance its beverage portfolio across Australia and the Asia-Pacific region [2][3]. Group 2: Strategic Importance - Australia is identified as a key market with a strong craft beer culture, serving as a strategic gateway for Tilray to access rapidly growing markets in Southeast Asia, Japan, and South Korea [2][4]. - The acquisition is expected to provide a solid operational base for Tilray to invest in BrewDog's brand and expand its offerings in the region, including introducing its U.S. beverage brands [3][4]. Group 3: Company Overview - Tilray Brands operates as a leading global lifestyle and consumer packaged goods company, with a diverse portfolio that includes craft beers, spirits, and non-alcoholic beverages [5][7]. - The company aims to elevate lives through innovative products and experiences, supporting over 40 brands across more than 20 countries [7].

Core Insights - Tilray Brands, Inc. (NASDAQ:TLRY) is recognized as one of the 12 best alcohol stocks to buy currently [1] Group 1: Acquisition Details - On March 2, 2026, Tilray Brands acquired select BrewDog assets for £33 million, which includes the global brand, intellectual property, UK brewing operations, and 11 brewpubs located in the UK and Ireland [2] - The acquired BrewDog business is projected to generate approximately $200 million in annual net revenue and an adjusted EBITDA of $6 million to $8 million, with positive cash flow expected in fiscal 2027 as integration progresses [2] - The company does not anticipate a significant EBITDA contribution from the acquisition in the last quarter of fiscal 2026 and expects temporary revenue timing issues in early fiscal 2027 due to licensing transfers [2] Group 2: Revenue Projections - Following the BrewDog acquisition, Tilray Brands expects its overall global beverage platform to generate around $500 million in annual revenue, contributing to consolidated annualized revenue of approximately $1.2 billion [3] - The company is currently in negotiations for additional BrewDog properties in the United States and Australia [3] Group 3: Company Overview - Tilray Brands, Inc. is a consumer packaged goods firm that specializes in medical cannabis research, cultivation, processing, and global distribution of cannabis products [4] - The company operates in several segments, including cannabis, distribution, beverage, and wellness [4]

分组1 - Tilray Brands has shifted its focus from being solely a marijuana company to becoming a brand manager, acquiring brands in marijuana, CBD, and alcohol sectors [4] - Despite the acquisitions, Tilray has not achieved sustainable profitability and has taken impairment charges across all business segments, indicating potential issues with its growth strategy [5] - The company's share count has increased by over 300% in the past five years due to acquisitions funded by stock, leading to dilution of existing shareholders [5] 分组2 - Altria has a more favorable risk/reward balance compared to Tilray, with a leading position in the U.S. tobacco market, holding a 40.5% market share in its Marlboro brand [8] - Altria's cigarette business, while in decline, remains sustainably profitable, allowing for dividend support and investment in new product development [9][11] - Despite past missteps, including unsuccessful investments in Juul and the marijuana sector, Altria continues to seek new growth opportunities, recently acquiring vape maker NJOY [12]